ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · P, page 1 of 8 · methodology v0.1 · reviewer not yet appointed
Compound index · P ETA-DOC-0004

Compound index — P

1,463 substances begin with P. 4 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, P-Dimethylaminoazobenzene – Pear.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
P-Dimethylaminoazobenzene US-DRUG Not yet graded
US: unapproved homeopathic
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010745
p-Hydroxy-N,N-dimethylphenethyl amine CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010746
Paba CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010747
Pachyrhizus erosus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010748
Pacific Ocean Perch US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010749
Pacific Oyster US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010750
Packera Aurea US-DRUG Not yet graded
US: drug for further processing
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010751
Packera Aurea Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010752
Paclitaxel EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedL01CD01; Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]; QL01CD01
Earliest US approval1992
Market presence65 US product listings · 24 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010753
Pacran® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Pacran® helps to inhibit the adhesion of P-fimbriated E. coli to the urinary tract cells.”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010754
Pacritinib US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Janus Kinase Inhibitors [MoA]
Earliest US approval2022
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010755
padeliporfin di-potassium EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01XD07
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010756
Padimate O US-DRUG Not yet graded
US: otc monograph drug
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010757
Padina pavonica-extract in Dictyolone® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Improves bone density through calcitrophic effects and through the physiological restoration of proteinous bone, particular in bone loss brought about by the aging process on normal healthy persons”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005601
Paecilomyces hepiali CA-NHP Not yet graded
CA licensed ingredient
Market presence171 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010758
Paecilomyces Variotii EU-NOVELUS-DRUG Not yet graded
Novel, not yet authorisedUS: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence7 US product listings
Parts in scopeWhole
Recorded fromEU-NOVEL, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010759
Paederia foetida CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010760
Paeonia anomala subsp. veitchii CA-NHP Not yet graded
CA licensed ingredient
Market presence236 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010761
Paeonia Californica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010762
Paeonia lactiflora CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Chinese peony; common garden peony; Paeonia albiflora Pall., Paeonia edulis Salisb., Paeonia lactea Pall., Paeonia sinensis Jacques
Market presence2,173 Canadian licensed products
Parts in scopeRoot and its alcoholic extract
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010763
Paeonia Lactiflora Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010764
Paeonia obovata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010765
Paeonia officinalis CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence66 Canadian licensed products
Parts in scopeFlowers
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010766
Paeonia Officinalis Root US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Anti-coagulant [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence40 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010767
Paeonia Officinalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010768
Paeonia suffruticosa CA-NHP Not yet graded
CA licensed ingredient
Market presence831 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010769
Paeonia veitchii CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010770
Paeonia X Suffruticosa Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010771
Paeoniae Alba CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010772
Paeoniae radix alba EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Peony root, white; Paeonia lactiflora Pallas
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-010773
Paeoniae radix rubra EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Peony root, red; Paeonia lactiflora Pall.;Paeonia veitchii Lynch
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-010774
Pafolacianine Sodium US-DRUG Not yet graded
US: drug for further processing
Class as recordedFluorescence Contrast Activity [MoA]; Optical Imaging Agent [EPC]
Earliest US approval2021
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010775
Palaeoloxodon nomadicus CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010776
Palbociclib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; L01EF01
Earliest US approval2015
Market presence25 US product listings · 12 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010777
Palifermin EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bla
Class as recordedFibroblast Growth Factor 7 [CS]; Increased Epithelial Proliferation [PE]; Mucocutaneous Epithelial Cell Growth Factor [EPC]; V03AF08
Earliest US approval2004
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010778
Paliperidone EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAtypical Antipsychotic [EPC]; N05AX13
Earliest US approval2006
Market presence123 US product listings · 25 FDA applications · 4 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010779
Palivizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; Fusion Protein Inhibitors [MoA]; J06BD01; Monoclonal [CS]
Earliest US approval1998
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010780
Palladium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Amide Local Anesthetic [EPC]
Market presence49 US product listings · 3 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010781
Palladium metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010782
Palm Kernel Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010783
Palm/oat oil fatty acid EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“In studies found to increase and prolong the sense of satiety. Helps to control appetite during the day. Increases the feeling of satiety”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010784
Palmaria palmata CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Fucus palmatus Linnaeus 1753, Ulva palmata (Linnaeus) Withering 1796, Ceramium palmatum (Linnaeus) Stackhouse 1797, Delesseria palmata (Linnaeus) J.V.Lamouroux 1813, Sarcophylla palmata (Linnaeus) Stackhouse 1816, Halymenia palmata (Linnaeus) C.Agardh 1817, Sphaerococcus palmatus (Linnaeus) Wahlenberg 1826, Rhodymenia palmata (Linnaeus) Greville 1830, Isomenia palmata (Linnaeus) Bachelot Pylaie 1830
Market presence270 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010785
Palmidrol US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010786
Palmitate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010787
Palmitic Acid EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence2 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010788
Palmitoyl Pentapeptide-4 US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010789
Palmitoyl Tetrapeptide-7 US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010790
Palmitoyl Tripeptide-1 US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010791
Palmitoyl Tripeptide-8 US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010792
palmitoyl-oleoyl phosphatidylglycerol EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010793
Palmitoylethanolamide (PEA) EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010794
Palonosetron EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedA04AA; A04AA05; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]
Earliest US approval2003
Market presence38 US product listings · 26 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010795
Palopegteriparatide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedH05AA; Parathyroid Hormone Analog [EPC]; Parathyroid Hormone [CS]
Earliest US approval2024
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010796
Palovarotene EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: bulk ingredient
Class as recordedM09AX11; Retinoid [EPC]; Retinoids [CS]
Earliest US approval2023
Market presence7 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010797
Paltusotine Hydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedH01CB06
Earliest US approval2025
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010798
Pamabrom US-DRUG Not yet graded
US: bulk ingredient
Market presence33 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010799
Pamidronate Disodium US-DRUG Not yet graded
US: anda
Class as recordedBisphosphonate [EPC]; Diphosphonates [CS]
Earliest US approval1991
Market presence7 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010800
Pamidronic Acid US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010801
Panax americanus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010802
Panax ginseng CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Aralia ginseng Baill.
Market presence4,194 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010803
Panax ginseng C.A. Meyer (Araliaceae) CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010804
Panax Ginseng Root US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010805
Panax Ginseng Root Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010806
Panax Ginseng Root Water US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010807
Panax Ginseng Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010808
Panax ginseng-Phosphatidylcholine complex CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010809
Panax Ginsenosides-Phosphatidylcholine complex CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010810
Panax notoginseng CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Aralia quinquefolia var. notoginseng Burkill
Market presence548 Canadian licensed products
Parts in scopeLeaves, roots and seeds
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010811
Panax Notoginseng Root US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010812
Panax pseudoginseng EU-NOVEL Not yet graded
Not novel in supplements
also: Aralia pseudoginseng Benth. ex C.B.Clarke
Parts in scopeLeaves, roots and seeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010813
Panax quinquefolium CA-NHP Not yet graded
CA licensed ingredient
Market presence67 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010814
Panax quinquefolius CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Aralia quinquefolia (L.) Decne. & Planch.
Market presence1,424 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010815
Panax Quinquefolius Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010816
Panax saponins CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010817
Pancreas CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010818
pancreas powder EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedA09AA02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010819
Pancreas suis CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010820
Pancreatic Enzymes CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence319 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“For a better digestive process”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-010821
Pancreatic extract CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010822
Pancreatin CA-NHP Not yet graded
CA licensed ingredient
Market presence102 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010823
Pancreatin 8X CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010824
Pancreatin USP 28 CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010825
Pancreatinum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010826
Pancrelipase CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence20 US product listings · 45 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010827
Pancrelipase Amylase US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Earliest US approval1996
Market presence52 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010828
Pancrelipase Lipase US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence52 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010829
Pancrelipase Protease US-DRUG Not yet graded
US: bla
Market presence47 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010830
Pancuronium Bromide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1972
Market presence3 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010831
Pandalus borealis CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010832
Pandanus amaryllifolius EU-NOVEL Not yet graded
Novel, not yet authorised
also: Pandanus odorus Ridl.; Pandanus latifolius Hassk.
Parts in scopeLeaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010833
Pandanus Tectorius Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedBlood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010834
pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010835
Panicum miliaceum CA-NHP Not yet graded
CA licensed ingredient
Market presence111 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010836
Panicum Miliaceum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010837
Panitumumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; Epidermal Growth Factor Receptor Antagonist [EPC]; HER1 Antagonists [MoA]; L01XC08
Earliest US approval2006
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010838
Panobinostat Lactate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XH03
Earliest US approval2015
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010839
Panthenol US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAdenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]; Arteriolar Vasodilation [PE]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010840
pantoprazole EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedA02BC02; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
Earliest US approval2000
Market presence199 US product listings · 48 FDA applications · 5 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010841
Pantothenic Acid CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 4 authorised / 1 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Earliest US approval1993
Market presence54 US product listings · 1 FDA applications · 5,745 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Pantothenic acid contributes to normal energy-yielding metabolism”AuthorisedArt.13(1)EFSA opinion
“Pantothenic acid contributes to normal mental performance”AuthorisedArt.13(1)EFSA opinion
“Pantothenic acid contributes to normal synthesis and metabolism of steroid hormones, vitamin D and some neurotransmitters”AuthorisedArt.13(1)EFSA opinion
“Pantothenic acid contributes to the reduction of tiredness and fatigue”AuthorisedArt.13(1)EFSA opinion
“Pantothenic acid supports healthy hormone balance. Pantothenic acid is required for normal adrenal function”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-010842
Papain CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 2 refusedCA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Blood Coagulation Factor [EPC]
Market presence3 US product listings · 2,177 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Supports normal immune function /supports body own defence mechanisms”Non-authorisedArt.13(1)EFSA opinion
“Digestive aid, protein digestion”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-010843
Papaver rhoeas CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010844
Papaver Rhoeas Flower US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010846
Papaver rhoeas L. EU-NOVEL Not yet graded
Not novel in supplements
also: Papaver aegadicum Lojac.
Parts in scopeSeeds; Flowers; Leaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010845
Papaverine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence21 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010847
Papaya EU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 2 refusedUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Supports pancreas activity and protein break-up. Papaya breaks down proteins and relieves after a heavy meal and when traveling in areas with different food hygiene. The papain enzymes in papaya break down proteins and activates digestive enzymes.”Non-authorisedArt.13(1)EFSA opinion
“Helps to reduce localized excess fat. - Helps to limit cellulitis thanks to its proteolytic effect”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010848
Papaya carica CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010849
Papaya enzyme CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010850
Papaya Seed US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010851
Paprika US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010853
para-Aminobenzoic acid CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 2 refusedCA licensed ingredient
Market presence264 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“helps maintain hair, nails and skin in optimum condition”Non-authorisedArt.13(1)EFSA opinion
“helps maintain hair, nails and skin in optimum condition”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-010854
para-aminosalicylic acid EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ04AA01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010855
para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Chlorofentanyl -N- propionamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010856
para-Chloroisobutyryl fentanyl US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesN-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4-; yl)isobutyramide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010857
para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Fluoro furanyl fentanyl -N- furan-2-carboxamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010858
para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Fluoro valeryl fentanyl -N- pentanamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010859
para-Fluorobutyryl fentanyl US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesN-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-; yl)butyramide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010860
para-Fluorofentanyl US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesChina White; fentanyl
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010861
para-Hydroxy-alpha-[(methylamino)methyl]benzyl alcohol CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010862
para-Methoxybutyryl fentanyl US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesN-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4-; yl)butyramide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010863
para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Methoxyfuranyl fentanyl -N- furan-2-carboxamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010864
para-Methoxymethamphetamine (PMMA); 1-(4-methoxyphenyl)-N-methylpropan-2-amine US-CSA Not yet graded
CSA Schedule I
also: para-Methoxymethamphetamine ; 1- -N-methylpropan-2-amine
Class as recordedDEA: stimulant
DEA other names(Positional isomer: methoxyphenamine (OMMA))
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010865
para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Methylcyclopropylfentanyl -N- cyclopropanecarboxamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010866
para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) US-CSA Not yet graded
CSA Schedule Inarcotic
also: para-Methylfentanyl -N- propionamide; also known as 4-methylfentanyl)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010867
Parachlorella kessleri EU-NOVEL Not yet graded
Not novel in food
also: Nováková 1969; Chlorella kessleri Fott &
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010868
Paraffin CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]
Market presence9 US product listings · 2 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010869
Paraffins, CHLORO- US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010870
Paraffinum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010871
Parahexyl US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesSynhexyl
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010872
Paraldehyde US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesParal
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010873
Paramethadione US-DRUG Not yet graded
Earliest US approval1949
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010874
Paramethasone Acetate US-DRUG Not yet graded
Earliest US approval1961
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010875
Parapolybia varia CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010876
Paraquat Dichloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010877
Parathormonum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010878
Parathyroid Hormone CA-NHPEU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnCA licensed ingredientUS: bulk ingredient
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations
Earliest US approval2015
Market presence5 US product listings · 1 FDA applications · 1 EU medicines · 2 Canadian licensed products
Recorded fromCA-NHP, EU-MED, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-010879
Paratyphoidinum B CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010880
parecoxib EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bulk ingredient
Class as recordedM01AH04
Market presence4 US product listings · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010881
Pareira brava CA-NHP Not yet graded
CA licensed ingredient
Market presence35 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010882
Pargyline Hydrochloride US-DRUG Not yet graded
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010883
Paricalcitol US-DRUG Not yet graded
US: anda
Class as recordedCholecalciferol [CS]; Ergocalciferols [CS]; Vitamin D Analog [EPC]; Vitamin D2 Analog [EPC]
Earliest US approval1998
Market presence53 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010884
Parietaria Officinalis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings · 5 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010885
Paris polyphylla CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010886
Paris polyphylla var. chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence33 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010887
Paris polyphylla var. yunnanensis CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010888
Paris Quadrifolia CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Market presence11 US product listings · 11 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010889
Paritaprevir EU-MEDUS-DRUG Not yet graded
EU medicine: Withdrawn
Class as recordedJ05AP53
Earliest US approval2015
Market presence2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010890
Parkinsonia Florida Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010891
Parmelia perlata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010892
Paromomycin Sulfate US-DRUG Not yet graded
US: anda
Class as recordedAntiprotozoal [EPC]
Earliest US approval1969
Market presence5 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010893
Parotidinum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010894
Paroxetine Mesylate US-DRUG Not yet graded
US: anda
Class as recordedSerotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
Earliest US approval1992
Market presence194 US product listings · 35 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010895
Parsaclisib hydrochloride EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01EM04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010896
Parsley US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010897
Parsnip US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010898
Parthenium Hysterophorus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010899
Parthenocissus Quinquefolia Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010900
Partially hydrolysed chicken eggshell membrane CA-NHP Not yet graded
CA licensed ingredient
Market presence193 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010901
Partially hydrolysed guar gum CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 9 refusedCA licensed ingredient
Market presence64 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Diet rich in fiber can help you maintain good cardiovascular health Dietary fiber helps maintain healthy cholesterol levels to promote overall heart health Dietary fiber helps maintain healthy blood pressure to promote overall heart health Diets rich in fiber can help promote healthy triglyceride levels”Non-authorisedArt.13(1)EFSA opinion
“Diet rich in fiber can help you maintain good cardiovascular health Dietary fiber helps maintain healthy cholesterol levels to promote overall heart health Dietary fiber helps maintain healthy blood pressure to promote overall heart health Diets rich in fiber can help promote healthy triglyceride levels”Non-authorisedArt.13(1)EFSA opinion
“Dietary fiber helps keep your blood sugar levels constant”Non-authorisedArt.13(1)EFSA opinion
“Dietary fiber helps maintain a healthy immune system by strengthening your body's natural defenses. Dietary fiber helps promote overall immune system health. Dietary Fiber helps boost your body's natural immunity”Non-authorisedArt.13(1)EFSA opinion
“Eating a diet high in fiber can help control postprandial glucose levels and serum lipid profiles and promote healthy triglyceride levels Dietary fiber helps improve glycemic control so you maintain normal blood sugar and insulin levels essential for good health PHGG helps to regulate plasma glucose levels and glycemic index of the foods after meals.”Non-authorisedArt.13(1)EFSA opinion
“Eating a diet high in fiber can help you control your weight Eating a diet high in fiber can help you maintain your weight by helping to curb your cravings. Diets rich in soluble fiber may help decrease feelings of hunger”Non-authorisedArt.13(1)EFSA opinion
“Eating a diet high in fiber can help you control your weight Eating a diet high in fiber can help you maintain your weight by helping to curb your cravings. Diets rich in soluble fiber may help decrease feelings of hunger”Non-authorisedArt.13(1)EFSA opinion
“PHGG is fermented in the gut leading to the production of the beneficial SCFA. PHGG helps promote colon health PHGG nourishes the digestive tract, where 70% of immune function occurs.”Non-authorisedArt.13(1)EFSA opinion
“PHGG promotes the growth of beneficial intestinal bacteria (probiotics) that are important for the maintenance of the natural digestive balance PHGG supports the natural, beneficial microflora PHGG contributes to proper digestive function by regulating the microflora and short chain fatty acid production. PHGG helps promote healthy intestinal flora to support bowel function PHGG helps maintain digestive balance by…”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-010902
Partially hydrolyzed collagen CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010903
Partially hydrolyzed guar gum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010904
Pascopyrum Smithii Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010905
Pasireotide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedH01CB05; Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
Earliest US approval2014
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010906
Pasireotide Diaspartate US-DRUG Not yet graded
Earliest US approval2012
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010907
Paspalum Notatum Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence30 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010908
Passalora Fulva US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010909
Passer Montanus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010910
Passiflora CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010911
Passiflora caerulea CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010912
Passiflora edulis CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Passiflora cuneifolia Cav.
Market presence21 Canadian licensed products
Parts in scopeFruit
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010913
Passiflora Edulis Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010914
Passiflora incarnata CA-NHP Not yet graded
CA licensed ingredient
Market presence1,152 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010915
Passiflora Incarnata Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010916
Passiflora Incarnata Flowering TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence154 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010917
Passiflora Incarnata TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antimalarial [EPC]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010918
Passiflora Incarnata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010919
Passiflorae herba CA-NHPEU-HERB Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredient
also: Passion Flower; Passiflora incarnata L.
Class as recordedherbal: Sleep disorders and temporary insomnia;Mental stress and moo
Market presence5 Canadian licensed products
Recorded fromCA-NHP, EU-HERB — 2 of 7 registers
Etalyn identifierETA-C-010920
Pasteurella Multocida US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010921
Pastinaca sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010922
Patala CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010923
Patiromer US-DRUG Not yet graded
US: nda
Class as recordedPotassium Binder [EPC]; Potassium Ion Binding Activity [MoA]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010924
Patiromer Sorbitex Calcium EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedV03AE09
Earliest US approval2015
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010925
Patisiran EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedDecreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; N07; RNA
Earliest US approval2018
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010926
Patrinia scabiosifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence61 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010927
Patrinia villosa CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010928
Patritumab US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010929
Patritumab Deruxtecan US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010930
Paullinia cupana CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Paullinia brasiliensis Lodd. ex Radlk.
Market presence585 Canadian licensed products
Parts in scopeFruits and seeds
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-010931
Paullinia Cupana Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010932
Paullinia sorbilis CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010933
Paulliniae semen CA-NHPEU-HERB Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredient
also: Guarana; Paullinia cupana Kunth;syn. Paullinia sorbilisMart
Class as recordedherbal: Fatigue and weakness
Market presence1 Canadian licensed products
Recorded fromCA-NHP, EU-HERB — 2 of 7 registers
Etalyn identifierETA-C-010934
Pazopanib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2009
Market presence21 US product listings · 7 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010935
PB-22 US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesQUPIC; PB-22
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010936
PEA CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence3 US product listings · 2 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-010938
Pea Protein CA-NHP Not yet graded
CA licensed ingredient
Market presence909 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010939
Pea protein concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence70 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010940
Pea protein isolate CA-NHP Not yet graded
CA licensed ingredient
Market presence26 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010941
Pea Proteins CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010942
Peanut US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010943
Peanuts, Peanut butter, Peanut oil EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Consuming a small handful, about 30 grams, of peanuts a day as part of a diet low in saturated fat helps to achieve healthy cholesterol levels and promotes heart health. Consuming two tablespoons, about 30g, of peanut butter a day as part of a diet low in saturated fat helps to achieve healthy cholesterol levels and promotes heart health. Consuming two tablespoons, about 30 grams of peanut oil a day as part of a…”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010944
Pear US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010945